Barclays »

Avadel Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.1M 393k 13.11
2024-06-30 $3.8M 269k 14.06